Technical University of Munich

Running trials

• Recruiting

  HEARTBEAT-TROP. Polyethylene Glycol Precipitation to Unmask Macrotroponin

  NCT07726420· Source

• Recruiting

  Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy

  NCT07077005· Source

• Enrolling by invitation

  Virtual Reality-Augmented At-Home tDCS for Major Depression

  NCT07146269· Source

• Recruiting

  40 Hz Visual Stimulation as an Intervention in Schizophrenia

  NCT06907420· Source

• Recruiting

  Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial

  NCT06533163· Source

• Recruiting

  Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis

  NCT06389968· Source

• Active, not recruiting

  Ultra-high-caloric, Fatty Diet in ALS

  NCT06280079· Source

• Recruiting

  The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

  NCT06283927· Source

• Recruiting

  The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

  NCT06273176· Source

• Recruiting

  The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

  NCT06146725· Source

• Recruiting

  The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)

  NCT06146738· Source

• Recruiting

  The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

  NCT06118723· Source

• Active, not recruiting

  Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

  NCT04246203· Source

• Active, not recruiting

  Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

  NCT04230759· Phase 2· Source

• Active, not recruiting

  Automatic PredICtion of Edema After Stroke

  NCT04057690· Source

• Active, not recruiting

  Tumor-specific T Cells in Lung Cancer

  NCT02515760· Source

• Recruiting

  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  NCT01574053· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Glioblastoma6 recruiting
• Childhood cancers1 recruiting
• Coronary artery disease1 recruiting
• Depression1 recruiting
• Huntington's disease1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Multiple sclerosis1 recruiting
• Schizophrenia1 recruiting

Researchers

• SLStefan F Lichtenthaler

Closed trials

• Completed

  Predicting Outcomes of Breast-Conserving Surgery in Breast Cancer Patients Using the Modified 5-Item Frailty Index

  NCT06770647· Source

• Completed

  Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

  NCT06182085· Phase 2· Source

• Completed

  Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment

  NCT05261256· Source

• Completed

  A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

  NCT03987295· Phase 2· Source

• Completed

  ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease

  NCT03622905· Source

• Completed

  Personalized Nutrition and eHealth: Lifestyle Intervention (LION) Study for Weight Loss Maintenance

  NCT04023942· Source

• Completed

  Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy

  NCT03081143· Phase 2/3· Source

• Terminated

  A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients

  NCT02088060· Phase 2· Source

• Completed

  Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers

  NCT02087592· Source

• Completed

  Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

  NCT01272050· Phase 3· Source

Trial sites

• Technical University of Munich2 trials
• Technische Universitaet Muenchen0 trials
• Technische Universität München3 trials
• Dept. of Psychiatry and Psychotherapy, Technical University Munich1 trial
• Division of Thoracic Surgery, Technical University of Munich, Munich, Germany1 trial
• Institute for Nutritional Medicine, Technical University of Munich1 trial
• Institute of Preventive Pediatrics, Department of Sport and Health Sciences, Technical University of Munich, Germany1 trial
• Technical University Munich8 trials
• Technical University of Munich2 trials
• Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy2 trials
• Technische Universitaet Muenchen2 trials
• Technische Universität München4 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Alzheimer disease116 works · 2 trials
• Heart failure103 works · 0 trials
• Prostate cancer80 works · 1 trial
• Pancreatic cancer70 works · 1 trial
• Schizophrenia69 works · 2 trials
• Colorectal cancer68 works · 0 trials
• Coronary artery disease58 works · 1 trial
• Multiple sclerosis49 works · 1 trial
• Atrial fibrillation48 works · 0 trials
• Melanoma46 works · 0 trials
• Glioblastoma34 works · 6 trials
• Head and neck cancer33 works · 0 trials
• Type 1 diabetes31 works · 0 trials
• Atopic dermatitis (eczema)28 works · 0 trials
• Sarcoma24 works · 0 trials
• Neuroendocrine tumours23 works · 0 trials
• Acute myeloid leukaemia23 works · 0 trials
• ALS (motor neurone disease)22 works · 1 trial
• Long COVID and ME/CFS20 works · 0 trials
• Frontotemporal dementia20 works · 1 trial
• Neuromyelitis optica (NMOSD)15 works · 0 trials
• Hepatitis B15 works · 0 trials
• Amyloidosis11 works · 0 trials
• Hypertrophic cardiomyopathy10 works · 1 trial
• Familial hypercholesterolaemia7 works · 0 trials
• Duchenne muscular dystrophy6 works · 0 trials